FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Richman

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Living Beings

Physiology

Lymphocyte Activation

Co-author Network

Publications

TOP 3
David P Richman; Joachim Schnier; Michael Ferns; Ricardo A Maselli; Kayoko Nishi; Peter Pytel; Mark A Agius
Animal models of antimuscle-specific kinase myasthenia.
David P Richman; Chih-Yung Tang; Pang-Yen Tseng; Wei-ping Yu; Yawei Yu; Ting-Ting Lee; Ricardo A Maselli; Tsung-Yu Chen
Dominantly inherited myotonia congenita resulting from a mutation that increases open probability of the muscle chloride channel CLC-1.
Andrew J Skalsky; Jay J Han; Bjorn Oskarsson; David P Richman
Current pharmacologic management in selected neuromuscular diseases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Richman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: David P Richman; Joachim Schnier; Michael Ferns; Ricardo A Maselli; Kayoko Nishi; Peter Pytel; Mark A Agius
Animal models of antimuscle-specific kinase myasthenia.
Annals of the New York Academy of Sciences 2012;1274():140-7.
2012: David P Richman; Chih-Yung Tang; Pang-Yen Tseng; Wei-ping Yu; Yawei Yu; Ting-Ting Lee; Ricardo A Maselli; Tsung-Yu Chen
Dominantly inherited myotonia congenita resulting from a mutation that increases open probability of the muscle chloride channel CLC-1.
Neuromolecular medicine 2012;14(4):328-37.
2012: Andrew J Skalsky; Jay J Han; Bjorn Oskarsson; David P Richman
Current pharmacologic management in selected neuromuscular diseases.
Physical medicine and rehabilitation clinics of North America 2012;23(4):801-20.
2012: David P Richman; Joachim Schnier; Robert L Wollmann; Jolene Mi Chang; Michael Ferns; Ricardo A Maselli; Stuart W Morell; Kayoko Nishi; Mark A Agius
Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.
Archives of neurology 2012;69(4):453-60.
2012: David P Richman
Antibodies to low density lipoprotein receptor-related protein 4 in seronegative myasthenia gravis.
Archives of neurology 2012;69(4):434-5.
2011: Jee Young Kim; Kee Duk Park; David P Richman
Treatment of myasthenia gravis based on its immunopathogenesis.
Journal of clinical neurology (Seoul, Korea) 2011;7(4):173-83.
2011: Susan S Kim; David P Richman; Scott S Zamvil; Mark A Agius
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice.
Journal of the neurological sciences 2011;306(1-2):9-15.
2011: Victoria Wong; Peter Adamczyk; Brian Dahlin; David P Richman; Vicki Wheelock
Cerebral venous sinus thrombosis presenting with auditory hallucinations and illusions.
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2011;24(1):40-2.
2009: Beau M Ances; D Sisti; F Vaida; C L Liang; O Leontiev; J E Perthen; R B Buxton; D Benson; D M Smith; S J Little; David P Richman; D J Moore; R J Ellis
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.
Neurology 2009;73(9):702-8.
2008: Donald B Sanders; I K Hart; R Mantegazza; S S Shukla; Zaeem A Siddiqi; marc de baets; Arthur Melms; M W Nicolle; N Solomons; David P Richman
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
Neurology 2008;71(6):400-6.
2008: Jennifer A Anderson; Jarae J Ng; Constance Bowe; Craig M McDonald; David P Richman; Robert L Wollmann; Ricardo A Maselli
Variable phenotypes associated with mutations in DOK7.
Muscle & nerve 2008;37(4):448-56.
2003: David P Richman; Mark A Agius
Treatment of autoimmune myasthenia gravis.
Neurology 2003;61(12):1652-61.
2003: David P Richman; Mark A Agius
Treatment principles in the management of autoimmune myasthenia gravis.
Annals of the New York Academy of Sciences 2003;998():457-72.
2003: Mark A Agius; David P Richman; Robert H Fairclough; Johan A Aarli; Nils Erik Gilhus; Fredrik Romi
Three forms of immune myasthenia.
Annals of the New York Academy of Sciences 2003;998():453-6.
2003: Robert H Fairclough; Mark A Agius; Eswari Gudipati; Laura Silvian; Brent Hamaoka; Christopher C Beltzner; Mike Y Lin; Anthony R Chuang; David P Richman
Agonist-induced transitions of the acetylcholine receptor.
Annals of the New York Academy of Sciences 2003;998():101-13.
2001: Peter F Roberts; F Venuta; E Rendina; T De Giacomo; G F Coloni; David M Follette; David P Richman; John R Benfield
Thymectomy in the treatment of ocular myasthenia gravis.
The Journal of thoracic and cardiovascular surgery 2001;122(3):562-8.
2001: Ricardo A Maselli; D Z Kong; Constance Bowe; Craig M McDonald; William G Ellis; Mark A Agius; Christopher M Gomez; David P Richman; Robert L Wollmann
Presynaptic congenital myasthenic syndrome due to quantal release deficiency.
Neurology 2001;57(2):279-89.
1998: Robert H Fairclough; GM Twaddle; Eswari Gudipati; Mike Y Lin; David P Richman
Differential surface accessibility of alpha(187-199) in the Torpedo acetylcholine receptor alpha subunits.
Journal of molecular biology 1998;282(2):317-30.
1998: Robert H Fairclough; GM Twaddle; Eswari Gudipati; R J Stone; David P Richman; D A Burkwall; R Josephs
Mapping the mAb 383C epitope to alpha 2(187-199) of the Torpedo acetylcholine receptor on the three-dimensional model.
Journal of molecular biology 1998;282(2):301-15.
1998: CA Kirvan; S Zhu; David P Richman; Mark A Agius
Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
Annals of the New York Academy of Sciences 1998;841():466-8.
1998: David P Richman; Mark A Agius; CA Kirvan; Christopher M Gomez; Robert H Fairclough; B L Dupont; Ricardo A Maselli
Antibody effector mechanisms in myasthenia gravis. The complement hypothesis.
Annals of the New York Academy of Sciences 1998;841():450-65.
1998: Mike Y Lin; GM Twaddle; Eswari Gudipati; David P Richman; Robert H Fairclough
MAb 383C binds to the alpha-subunit of the acetylcholine receptor associated with the high-affinity tubocurarine site.
Annals of the New York Academy of Sciences 1998;841():101-3.
1998: Robert H Fairclough; Eswari Gudipati; Mike Y Lin; GM Twaddle; David P Richman; D A Burkwall; R Josephs
A role for alpha(187-199) in the conversion of agonist binding energy to the opening of the acetylcholine receptor ion channel.
Annals of the New York Academy of Sciences 1998;841():87-92.
1997: Walter G Bradley; J Daube; J R Mendell; J Posner; David P Richman; B T Troost; T R Swift
Quality improvement in neurology residency programs. Report of the Quality Improvement Committee of the Association of University Professors of Neurology.
Neurology 1997;49(5):1205-7.
1997: Ricardo A Maselli; William G Ellis; RN Mandler; F Sheikh; G Senton; S Knox; H Salari-Namin; Mark A Agius; Robert L Wollmann; David P Richman
Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic study.
Muscle & nerve 1997;20(10):1284-95.
1995: David P Richman
Neurology.
The Western journal of medicine 1995;163(5):470.
1994: Mirta Mihovilovic; D Donnelly-Roberts; David P Richman; Marino Martinez-Carrion
Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(12):5997-6002.
1994: David P Richman; Mark A Agius
Myasthenia gravis: pathogenesis and treatment.
Seminars in neurology 1994;14(2):106-10.
1994: David P Richman; Mark A Agius
Acquired myasthenia gravis. Immunopathology.
Neurologic clinics 1994;12(2):273-84.
1994: V J DeFilippi; David P Richman; Mark K Ferguson
Transcervical thymectomy for myasthenia gravis.
The Annals of thoracic surgery 1994;57(1):194-7.
1993: Ricardo A Maselli; R L Wollman; C Leung; B Distad; S Palombi; David P Richman; E F Salazar-Grueso; R P Roos
Neuromuscular transmission in amyotrophic lateral sclerosis.
Muscle & nerve 1993;16(11):1193-203.
1993: Mark A Agius; B Sanyal; David P Richman
Molecular structure of a monoclonal antiacetylcholine receptor antibody and of a corresponding monoclonal antiidiotopic antibody.
Annals of the New York Academy of Sciences 1993;681():274-5.
1993: David P Richman; Robert L Wollmann; Ricardo A Maselli; Christopher M Gomez; A L Corey; Mark A Agius; Robert H Fairclough
Effector mechanisms of myasthenic antibodies.
Annals of the New York Academy of Sciences 1993;681():264-73.
1993: Q Xu; Mark A Agius; Eswari Gudipati; Robert H Fairclough; David P Richman
An immunogenic self-peptide for T cells in mice with experimental myasthenia.
Annals of the New York Academy of Sciences 1993;681():1-4.
1993: Q Xu; Robert H Fairclough; David P Richman
Effects of D-penicillamine on multiple immunogenic epitopes of the acetylcholine receptor.
Annals of the New York Academy of Sciences 1993;681():335-8.
1993: Q Xu; GM Twaddle; David P Richman; Robert H Fairclough
Characterization of the epitope of an antiacetylcholine receptor antibody that inhibits fifty percent of alpha-bungarotoxin binding.
Annals of the New York Academy of Sciences 1993;681():175-8.
1993: Q Xu; Robert H Fairclough; David P Richman
Interaction of antiacetylcholine receptor monoclonal antibodies with the acetylcholine receptor.
Annals of the New York Academy of Sciences 1993;681():172-4.
1993: Robert H Fairclough; R Josephs; David P Richman
Imaging ligand binding sites on the Torpedo acetylcholine receptor.
Annals of the New York Academy of Sciences 1993;681():113-25.
1993: A R Berger; Joseph C Arezzo; Herbert H Schaumburg; G Skowron; Thomas C Merigan; Samuel A Bozzette; David P Richman; W Soo
2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients.
Neurology 1993;43(2):358-62.
1991: Ricardo A Maselli; Daniel P Mass; B J Distad; David P Richman
Anconeus muscle: a human muscle preparation suitable for in-vitro microelectrode studies.
Muscle & nerve 1991;14(12):1189-92.
1991: Ricardo A Maselli; David P Richman; Robert L Wollmann
Inflammation at the neuromuscular junction in myasthenia gravis.
Neurology 1991;41(9):1497-504.
1990: David P Richman; Robert H Fairclough; Q Xu; Mark A Agius
Noninflammatory immune mechanisms in diseases of the nervous system.
Research publications - Association for Research in Nervous and Mental Disease 1990;68():55-65.
1989: M A Chinchetru; javier marquez; J C Garcia-Borron; David P Richman; Marino Martinez-Carrion
Interaction of nicotinic acetylcholine receptor with two monoclonal antibodies recognizing different epitopes.
Biochemistry 1989;28(10):4222-9.
1989: Ricardo A Maselli; Deborah J Nelson; David P Richman
Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate.
The Journal of physiology 1989;411():271-83.
1988: Mark A Agius; C J Geannopoulos; Robert H Fairclough; David P Richman
Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(1):62-8.
1988: Ricardo A Maselli; B Jow; David P Richman; Deborah J Nelson
In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodies.
Annals of the New York Academy of Sciences 1988;540():523-4.
1987: Christopher M Gomez; David P Richman
Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(1):73-6.
1987: A L Corey; David P Richman; Mark A Agius; Robert L Wollmann
Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(10):3269-75.
1987: Mirta Mihovilovic; David P Richman
Monoclonal antibodies as probes of the alpha-bungarotoxin and cholinergic binding regions of the acetylcholine receptor.
The Journal of biological chemistry 1987;262(11):4978-86.
1987: D A Blair; Mirta Mihovilovic; Mark A Agius; Robert H Fairclough; David P Richman
Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia.
Annals of the New York Academy of Sciences 1987;505():155-67.
1987: Kari Stefansson; M E Dieperink; David P Richman; Linda S Marton
Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis.
Annals of the New York Academy of Sciences 1987;505():451-60.
1986: Mark A Agius; David P Richman
Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(7):2195-8.
1986: D A Blair; David P Richman; C J Taves; S Koethe
Monoclonal antibodies to acetylcholine receptor secreted by human x human hybridomas derived from lymphocytes of a patient with myasthenia gravis.
Immunological investigations 1986;15(4):351-64.
1985: A Noronha; David P Richman; B G Arnason
Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations.
Annals of neurology 1985;18(6):722-5.
1985: A L Corey; David P Richman; C A Shuman; Christopher M Gomez; B G Arnason
Use of monoclonal antiacetylcholine receptor antibodies to investigate the macrophage inflammation of acute experimental myasthenia gravis: refractoriness to a second episode of acute disease.
Neurology 1985;35(10):1455-60.
1985: Christopher M Gomez; David P Richman
Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(1):234-41.
1985: H C Chiu; K H Hsieh; T P Hung; David P Richman; B G Arnason
Effect of myasthenia serum and anti-acetylcholine receptor monoclonal antibody on the distributions of T-cell subsets in myasthenia patients and normal subjects.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 1985;3(1):30-6.
1985: Kari Stefansson; M E Dieperink; David P Richman; Christopher M Gomez; Linda S Marton
Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis.
The New England journal of medicine 1985;312(4):221-5.
1985: David P Richman
Treatment of myasthenia gravis.
Journal of neurology 1985;232(4):202-3.
1984: Mirta Mihovilovic; David P Richman
Modification of alpha-bungarotoxin and cholinergic ligand-binding properties of Torpedo acetylcholine receptor by a monoclonal anti-acetylcholine receptor antibody.
The Journal of biological chemistry 1984;259(24):15051-9.
1984: S F Atweh; J J Grayhack; David P Richman
A cholinergic receptor site on murine lymphocytes with novel binding characteristics.
Life sciences 1984;35(24):2459-69.
1984: D Donnelly; Mirta Mihovilovic; Jose M Gonzalez-Ros; José A Ferragut; David P Richman; Marino Martinez-Carrion
A noncholinergic site-directed monoclonal antibody can impair agonist-induced ion flux in Torpedo californica acetylcholine receptor.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(24):7999-8003.
1984: A Noronha; David P Richman
Simultaneous cell surface phenotype and cell cycle analysis of lymphocytes by flow cytometry.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1984;32(8):821-6.
1984: Kari Stefansson; M L Molnar; Linda S Marton; G K Molnar; Mirta Mihovilovic; R C Tripathi; David P Richman
Myelin-associated glycoprotein in human retina.
Nature 1984;307(5951):548-50.
1984: Christopher M Gomez; Robert L Wollmann; David P Richman
Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor.
Acta neuropathologica 1984;63(2):131-43.
1983: Christopher M Gomez; David P Richman
Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(13):4089-93.
1982: S Yachnin; David P Richman
Mevalonic acid in conjunction with help from neutrophils induces DNA synthesis and cell cycling in human peripheral blood lymphocytes.
Cellular immunology 1982;72(2):248-62.
1982: E J Dropcho; David P Richman; J P Antel; B G Arnason
Defective mitogenic responses in myasthenia gravis and multiple sclerosis.
Annals of neurology 1982;11(5):456-62.
1981: S A Burres; J W Crayton; Christopher M Gomez; David P Richman
Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
Annals of neurology 1981;9(6):563-8.
1981: Christopher M Gomez; David P Richman; S A Burres; B G Arnason; P W Berman; F W Fitch
Monoclonal hybridoma anti-acetylcholine receptor antibodies: antibody specificity and effect of passive transfer.
Annals of the New York Academy of Sciences 1981;377():97-109.
1981: S A Burres; M E Kanter; David P Richman; B G Arnason
Studies on the pathophysiology of chronic D-penicillamine-induced myasthenia.
Annals of the New York Academy of Sciences 1981;377():640-51.
1981: David P Richman; J P Antel; J B Burns; B G Arnason
Nicotinic acetylcholine receptor on human lymphocytes.
Annals of the New York Academy of Sciences 1981;377():427-35.
1980: A B Noronha; David P Richman; B G Arnason
Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis.
The New England journal of medicine 1980;303(13):713-7.
1980: J P Antel; J J Oger; E Dropcho; David P Richman; H H Kuo; B G Arnason
Reduced T-lymphocyte cell reactivity as a function of human aging.
Cellular immunology 1980;54(1):184-92.
1980: David P Richman; Christopher M Gomez; P W Berman; S A Burres; F W Fitch; B G Arnason
Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia.
Nature 1980;286(5774):738-9.
1980: David P Richman
Lymphocyte cell-cycle analysis by flow cytometry. Evidence for a specific postmitotic phase before return to G0.
The Journal of cell biology 1980;85(2):459-65.
1979: David P Richman; B G Arnason
Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(9):4632-5.
1979: C M Gomez; David P Richman; P W Berman; S A Burres; B G Arnason; F W Fitch
Monoclonal antibodies against purified nicotinic acetylcholine receptor.
Biochemical and biophysical research communications 1979;88(2):575-82.
1979: S A Burres; David P Richman; J W Crayton; B G Arnason
Penicillamine-induced myasthenic responses in the guinea pig.
Muscle & nerve 1979;2(3):186-90.
1979: David P Richman; J P Antel; J W Patrick; B G Arnason
Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site.
Neurology 1979;29(3):291-6.
1978: J P Antel; David P Richman; M E Medof; B G Arnason
Lymphocyte function and the role of regulator cells in multiple sclerosis.
Neurology 1978;28(9 Pt 2):106-10.
1978: David P Richman; E J Dropcho; J P Antel; B G Arnason
Contrasting defects of T-lymphocyte mitogenic response in multiple sclerosis and myasthenia gravis.
Transactions of the American Neurological Association 1978;103():191-3.
1976: David P Richman; J Patrick; B G Arnason
Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
The New England journal of medicine 1976;294(13):694-8.
1976: J P Antel; David P Richman; B G Arnason
Immunogenetics and amyotrophic lateral sclerosis.
UCLA forum in medical sciences 1976;(19):151-71.
1975: R M Stewart; David P Richman; V S Caviness
Lissencephaly and Pachygyria: an architectonic and topographical analysis.
Acta neuropathologica 1975;31(1):1-12.
1974: David P Richman; R M Stewart; V S Caviness
Cerebral microgyria in a 27-week fetus: an architectonic and topographic analysis.
Journal of neuropathology and experimental neurology 1974;33(3):374-84.
1969: B G Arnason; David P Richman
Effect of oral contraceptives on experimental demyelinating disease.
Archives of neurology 1969;21(1):103-8.
1969: B G Arnason; David P Richman
Effects of estrogen, progestin and combined estrogen-progestin oral contraceptive preparations on experimental allergic encephalomyelitis.
Transactions of the American Neurological Association 1969;94():54-8.